CD8+ T cells perform two functions in the tumor microenvironment: (i) they kill cancer cells when they come into contact with them and (ii) inhibit the production of TNF from polarized macrophages, representing the conversion of classically activated macrophages (M1) to the anti-inflammatory state (M2)34. The gene discussed is CD8A; the disease is neoplasm.